Bio-Nucleonics is an independent biotechnology Corporation supplying specific radioisotopes for diagnostic and therapeutic use, principally in the practice of oncology, cardiology, rheumatology and endocrinology. The firm is focused to developing and marketing new therapeutic agents, and generic radiopharmaceuticals, Technetium-99m reagents, and medical devices. These products are essential for the detection and treatment of a variety of disorders including cardiovascular disease, cancer, autoimmune and endocrine system impairment.
